Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Non-cash Items (2020 - 2021)

Atea Pharmaceuticals (AVIR) has 2 years of Non-cash Items data on record, last reported at $31.2 million in Q4 2021.

  • For Q4 2021, Non-cash Items fell 88.76% year-over-year to $31.2 million; the TTM value through Dec 2021 reached $31.2 million, down 88.76%, while the annual FY2021 figure was $4.6 million, 98.36% down from the prior year.
  • Non-cash Items reached $31.2 million in Q4 2021 per AVIR's latest filing, down from $277.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $277.9 million in Q4 2020 and bottomed at $22.4 million in Q3 2020.